Works by Witzig, Thomas
Results: 228
Waldenström macroglobulinemia.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Heavy chain disease.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trial.
- Published in:
- Cancer Reports, 2023, v. 6, n. 1, p. 1, doi. 10.1002/cnr2.1662
- By:
- Publication type:
- Article
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01145-0
- By:
- Publication type:
- Article
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00942-3
- By:
- Publication type:
- Article
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00847-1
- By:
- Publication type:
- Article
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00847-1
- By:
- Publication type:
- Article
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
- By:
- Publication type:
- Article
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00598-x
- By:
- Publication type:
- Article
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
- By:
- Publication type:
- Article
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
- By:
- Publication type:
- Article
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00452-0
- By:
- Publication type:
- Article
JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00394-z
- By:
- Publication type:
- Article
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
- By:
- Publication type:
- Article
Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 6, p. N.PAG, doi. 10.1038/s41408-019-0208-6
- By:
- Publication type:
- Article
Alterations in cell proliferation and apoptosis in colon cancers with microsatellite instability.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 6, p. 1232, doi. 10.1002/ijc.22429
- By:
- Publication type:
- Article
Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-hodgkin lymphoma.
- Published in:
- International Journal of Cancer, 2003, v. 106, n. 5, p. 784, doi. 10.1002/ijc.11311
- By:
- Publication type:
- Article
Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 4, p. 259, doi. 10.1016/j.clml.2023.01.010
- By:
- Publication type:
- Article
Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. 618, doi. 10.1016/j.clml.2022.03.004
- By:
- Publication type:
- Article
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e815, doi. 10.1016/j.clml.2022.04.009
- By:
- Publication type:
- Article
TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S416, doi. 10.1016/S2152-2650(21)01935-2
- By:
- Publication type:
- Article
MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S408, doi. 10.1016/S2152-2650(21)01919-4
- By:
- Publication type:
- Article
IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
- By:
- Publication type:
- Article
Poster: TCL-461: Clinical Activity of Systemic VSV-IFNβ-NIS Oncolytic Virotherapy in Patients with Relapsed Refractory Hematologic Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S248, doi. 10.1016/S2152-2650(21)01560-3
- By:
- Publication type:
- Article
Poster: MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S246, doi. 10.1016/S2152-2650(21)01551-2
- By:
- Publication type:
- Article
Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
- By:
- Publication type:
- Article
Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
- By:
- Publication type:
- Article
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of Metformin Use on the Outcome of Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S270, doi. 10.1016/j.clml.2018.07.192
- By:
- Publication type:
- Article
Clinical Characteristics and Outcome of Transformed Diffuse Large B-Cell Lymphoma in the Rituximab Era: A SEER Database Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S362, doi. 10.1016/j.clml.2017.07.196
- By:
- Publication type:
- Article
Upregulation of TET Activity with Ascorbic Acid Induces Epigenetic Modulation of Lymphoma Cells.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S378, doi. 10.1016/j.clml.2017.07.223
- By:
- Publication type:
- Article
Impact of Alemtuzumab Therapy and Route of Administration in T-Prolymphocytic Leukemia: A Single-Center Experience.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
- Published in:
- British Journal of Haematology, 2006, v. 134, n. 6, p. 596, doi. 10.1111/j.1365-2141.2006.06232.x
- By:
- Publication type:
- Article
Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2006, v. 133, n. 2, p. 158, doi. 10.1111/j.1365-2141.2006.06003.x
- By:
- Publication type:
- Article
SHORT REPORT Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma.
- Published in:
- British Journal of Haematology, 2003, v. 123, n. 2, p. 305, doi. 10.1046/j.1365-2141.2003.04605.x
- By:
- Publication type:
- Article
Bone marrow angiogenesis and circulating plasma cells in multiple myeloma.
- Published in:
- British Journal of Haematology, 2003, v. 122, n. 2, p. 272, doi. 10.1046/j.1365-2141.2003.04428.x
- By:
- Publication type:
- Article
Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2003, v. 121, n. 2, p. 287, doi. 10.1046/j.1365-2141.2003.04265.x
- By:
- Publication type:
- Article
Bone marrow angiogenesis in multiple myeloma: effect of therapy.
- Published in:
- British Journal of Haematology, 2002, v. 119, n. 3, p. 665, doi. 10.1046/j.1365-2141.2002.03871.x
- By:
- Publication type:
- Article
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2001, v. 115, n. 4, p. 854, doi. 10.1046/j.1365-2141.2001.03149.x
- By:
- Publication type:
- Article
Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil.
- Published in:
- British Journal of Haematology, 2000, v. 108, n. 4, p. 737, doi. 10.1046/j.1365-2141.2000.01918.x
- By:
- Publication type:
- Article
Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disorders.
- Published in:
- British Journal of Haematology, 1999, v. 104, n. 1, p. 131, doi. 10.1046/j.1365-2141.1999.01136.x
- By:
- Publication type:
- Article
Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases.
- Published in:
- British Journal of Haematology, 1998, v. 101, n. 2, p. 296, doi. 10.1046/j.1365-2141.1998.00700.x
- By:
- Publication type:
- Article
Detection of monoclonal plasma cells in the peripheral blood of patients with primary amyloidosis.
- Published in:
- British Journal of Haematology, 1998, v. 100, n. 2, p. 326, doi. 10.1046/j.1365-2141.1998.00583.x
- By:
- Publication type:
- Article
Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity?
- Published in:
- British Journal of Haematology, 1995, v. 90, n. 2, p. 459, doi. 10.1111/j.1365-2141.1995.tb05175.x
- By:
- Publication type:
- Article
Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 1995, v. 89, n. 3, p. 640, doi. 10.1111/j.1365-2141.1995.tb08378.x
- By:
- Publication type:
- Article
Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma.
- Published in:
- British Journal of Haematology, 1994, v. 87, n. 2, p. 266, doi. 10.1111/j.1365-2141.1994.tb04908.x
- By:
- Publication type:
- Article
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 1, p. 101, doi. 10.1007/s00277-010-1028-8
- By:
- Publication type:
- Article
Targeting apoptosis pathways in cancer therapy.
- Published in:
- 2005
- By:
- Publication type:
- journal article